Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Study highlights racialized inequities in New York City police enforcement of COVID-19 mandates

New York City ZIP codes with a higher percentage of Black residents had significantly higher rates of COVID-19-specific criminal court summonses and public health and nuisance arrests in the early months of the COVID-19 pandemic, according to a new study by Columbia University Mailman School of Public Health.

12 Nov 2021

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

12 Nov 2021

Flu season emerging against the backdrop of COVID-19 pandemic

For the second straight year, flu season is emerging against the backdrop of the COVID-19 pandemic. While the number of flu cases was relatively low last year, experts at Johns Hopkins Medicine say that this year, it could be much higher.

11 Nov 2021

Western boom cities see spike in harmful ozone

The reduction of harmful ground-level ozone across most of the U.S. over the past several decades has been an air pollution success story.

10 Nov 2021

Study reveals cellular mechanism behind older adults' susceptibility to COVID-19

Among the populations most significantly affected by COVID-19 are the elderly and patients with preexisting medical conditions including diabetes, hypertension, obesity, metabolic syndrome, cardiovascular disease and chronic lung diseases like COPD and asthma.

8 Nov 2021

People of color, lower-income residents in DC disproportionally affected by air pollution

The rates of death and health burdens associated with air pollution are borne unequally and inequitably by people of color and those with lower household income and educational attainment in Washington, D.C., according to a new study.

8 Nov 2021

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

A new study by researchers at Hospital for Special Surgery (HSS) in New York City demonstrates over half of patients with rheumatic diseases who contracted COVID-19 during the pandemic and completed a COVID-19 survey, experienced so-called "long-haul" COVID, or prolonged symptoms of the infection, including loss of taste or smell, muscle aches and difficulty concentrating, for one month or longer.

7 Nov 2021

Maternal pre-pregnancy BMI linked to pediatric allergic disease development

A University of Ottawa-led study of nearly 250,000 children in Ontario over seven years – the largest of its kind – found a mother's weight before pregnancy may impact their newborn's risk of developing allergic diseases in early childhood, whereas weight gain during pregnancy did not seem to have the same effect.

1 Nov 2021

Investigation of Budesonide's mechanism of action against SARS-CoV-2

Researchers look to gain an understanding of the mechanism of action of budesonide in improving the prognosis of patients with SARS-CoV-2 infection.

1 Nov 2021

New project seeks to develop greener inhalers for treating asthma and COPD

Researchers are looking at ways to boost the performance and lower the environmental impact of millions of inhalers used for treating asthma and COPD.

29 Oct 2021

Environmental and social factors associated with higher rates of pediatric pneumonia

A new study led by researchers in the Louisiana State University Superfund Research Program demonstrates that children who are exposed to a certain type of environmental air pollution are more likely to contract community acquired pneumonia, or CAP, and to be hospitalized for longer periods of time.

29 Oct 2021

Radical decarbonization in cities has potential to dramatically improve child health, study says

Improved air quality in cities resulting from cutting carbon emissions could lead to large reductions in childhood asthma cases, premature births and incidences of babies born at an unhealthily low weight, according to a study carried out by researchers at the London School of Hygiene & Tropical Medicine.

29 Oct 2021

Large study reveals worldwide trends in childhood asthma rates

The prevalence of asthma in children was found to have decreased in low-income countries, but increased in lower-middle income countries, according to the latest phase of the largest face-to-face health survey ever conducted, published in The Lancet.

29 Oct 2021

Study offers hope for a new therapeutic option for patients with severe asthma

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.

28 Oct 2021

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Kawasaki disease (KD) is rare, with fewer than 6,000 diagnosed cases per year in the United States. It is most common in infants and young children and causes inflammation in the walls of some blood vessels in the body.

27 Oct 2021

Fermented soy product suppresses airway inflammation in animal models of asthma

Bronchial asthma causes symptoms such as wheezing and cough due to chronic airway inflammation, but there is no fundamental treatment for it, leaving a desire for new prevention and treatment methods.

26 Oct 2021

Health and climate change in Australia

The 2021 MJA–Lancet Countdown report represents a collaborative effort between University College London, and seven Australian institutions, mediated by The Lancet in partnership with The Medical Journal of Australia.

22 Oct 2021

New discovery can pave the way to better diagnostics and therapeutics for asthma and COPD

Rutgers researchers have discovered that people with asthma and chronic obstructive pulmonary disease have a protein in their lungs that leaks a small molecule into their bloodstream that restricts their breathing instead of relaxing their airways.

20 Oct 2021

New class of CXCR4 antagonists could prevent airway inflammation and atopic dermatitis

Aberrant CXCR4/CXCL12 signaling is involved in many pathophysiological processes such as cancer and inflammatory diseases. A natural fragment of serum albumin, named EPI-X4, has previously been identified as endogenous peptide antagonist andinverse agonistof CXCR4 and is a promising compound for the development of improved analogues for the therapy of CXCR4-associated diseases.

18 Oct 2021

Public health interventions, more hospitals associated with reduction in COVID-19 case-fatality rates

Counties that banned in-person religious gatherings and those with a greater number of hospitals per capita were associated with a decreased case-fatality rate of COVID-19 during the pandemic’s first wave, according to a new University of Michigan study.

15 Oct 2021

Asthma News and Research

Further Reading

Study highlights racialized inequities in New York City police enforcement of COVID-19 mandates

Will the future of global health rely upon addressing air pollution?

Flu season emerging against the backdrop of COVID-19 pandemic

Western boom cities see spike in harmful ozone

Study reveals cellular mechanism behind older adults' susceptibility to COVID-19

People of color, lower-income residents in DC disproportionally affected by air pollution

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

Maternal pre-pregnancy BMI linked to pediatric allergic disease development

Investigation of Budesonide's mechanism of action against SARS-CoV-2

New project seeks to develop greener inhalers for treating asthma and COPD

Environmental and social factors associated with higher rates of pediatric pneumonia

Radical decarbonization in cities has potential to dramatically improve child health, study says

Large study reveals worldwide trends in childhood asthma rates

Study offers hope for a new therapeutic option for patients with severe asthma

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Fermented soy product suppresses airway inflammation in animal models of asthma

Health and climate change in Australia

New discovery can pave the way to better diagnostics and therapeutics for asthma and COPD

New class of CXCR4 antagonists could prevent airway inflammation and atopic dermatitis

Public health interventions, more hospitals associated with reduction in COVID-19 case-fatality rates

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News